RGEN FY 2022 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$802M+19.5% YoY

Gross Profit

$456M56.9% margin

Operating Income

$225M28.0% margin

Net Income

$186M23.2% margin

EPS (Diluted)

$3.24

Cash Flow

Operating Cash Flow

$172M

Free Cash Flow

$39M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$621M

Stockholders' Equity

$1.9B

Cash & Equivalents

$523M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$802M	$671M	+19.5%
Gross Profit	$456M	$391M	+16.5%
Operating Income	$225M	$167M	+34.3%
Net Income	$186M	$128M	+45.0%